Mark Fladrich

Member of the Corporate Executive Board, Chief Commercial Officer

Mark Fladrich, Member of the Corporate Executive Board, Chief Commercial Officer Mark Fladrich
Member of the Corporate Executive Board,
Chief Commercial Officer

Mark Fladrich joined the Grünenthal Group in September 2017 as Chief Commercial Officer and member of the Corporate Executive Board.

He started a career in the pharmaceutical industry in 1988 and has been working on the commercial side of the business with AstraZeneca for 20 years.

Since 2011 Mark Fladrich has worked in major commercial Profit & Loss roles, including the position of Country President for Australia and New Zealand and the position of Area Vice President Southern and Western Europe.

In 2010, he was appointed Vice President Global Commercial Excellence with responsibility for pricing, market access, business insight, medical affairs, communications, sales, marketing, new channels capability development, portfolio management and forecasting.

In 2008, Mark Fladrich was promoted to Vice President Global Brands at the UK Headquarters where he assumed responsibility for the strategic marketing of the company’s Phase III projects as well as the marketed products across all therapeutic areas (oncology, diabetes, respiratory, CNS).